Ardent Health Partners Files For $100 Million IPO


  • Ardent Health has filed to raise $100 million in a U.S. IPO, although the final figure could be as high as $200 million.
  • Ardent is an acute care hospital owner with facilities primarily in the lower Midwest and Southern U.S. regions.
  • The firm has grown recently through several acquisitions and is owned by healthcare REIT Ventas.
  • I'll provide an update when we learn more details about the IPO from management.
  • This idea was discussed in more depth with members of my private investing community, IPO Edge. Start your free trial today »

ardent health partners ipo

Quick Take

Ardent Health Partners (ARDT) intends to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement.

The firm, formerly known as Behavioral Healthcare Corporation, operates a network of hospitals and healthcare facilities, mostly in the lower Midwest and South.

ARDT has grown recently through several acquisitions, so management’s pricing and valuation assumptions will be critical for the IPO’s potential value to investors.

Company & Technology

Nashville, Tennessee-based ARDT was founded in 1993 to acquire and develop a network of acute care hospital and healthcare facilities across Texas, New Mexico, Oklahoma, New Jersey, Idaho, Florida, and Kansas.

Management is headed by Director, President and CEO David T. Vandewater, who has been with the firm since its inception and was previously President and COO at Columbia/HCA Healthcare Corporation.

As of Sep. 30th, 2018, ARDT operated ‘31 acute care hospitals, including one managed hospital, two rehabilitation hospitals and two surgical hospitals, with a total of 4,718 licensed beds, and provided physician and other ancillary healthcare services through a network of more than 1,000 employed providers.’

Below is an overview image of the company’s geographic footprint:

Source: S-1 Filing

The company has also invested in various healthcare solution companies, including BSA Health, Hillcrest Healthcare, and Lovelace Health.

Market & Competition

According to a 2018 market research report by Market Research Future, the global acute hospital care market is projected to grow at a CAGR of 7.8% between 2017 and 2023.

The main factors driving market growth are the ‘rising incidences of trauma injury, the presence of a large base of the patient population, increasing number of hospitals, and unmet medical needs in emerging economies.’

North America dominates the market, while the Asia-Pacific region is projected to grow at the fastest rate due to the ‘rapidly developing healthcare technology, huge patient population, and high healthcare expenditure.’

Major companies that provide acute hospital care in the U.S. include:

  • HCA Holdings (HCA)
  • Community Health Systems (CYH)
  • Universal Health Services (UHS)
  • Tenet Healthcare Corporation (THC)
  • Vanguard Health System
  • Kindred Healthcare
  • PruittHealth
  • National HealthCare Corp (NHC)

Financial Performance

ARDT’s recent financial results can be summarized as follows:

  • Growing topline revenue from several recent acquisitions
  • Increased operating profit
  • Uneven operating margin
  • Fluctuating cash flow from operations

Below are the company’s pro forma financial results for the first nine months of 2018 (Unaudited, interim):

Source: Company Prospectus

Relevant financial metrics derived from the firm’s registration statement:

TTM Revenue


TTM Revenue

% Variance vs. Prior

To Q3 2018

$ 3,187,478,000



$ 3,877,756,000



$ 2,105,216,000

Operating Profit (Loss)


Operating Profit (Loss)

% Variance vs. Prior

To Q3 2018

$ 195,939,000



$ 199,469,000



$ 156,266,000

Operating Margin


Operating Margin

To Q3 2018






Cash Flow From Operations


Cash Flow From Operations

To Q3 2018

$ 63,292,000


$ 119,469,000


$ 85,775,000

Sources: Company Prospectus, IPO Edge

As of September 30, 2018, the company had $61.0 million in cash and $2.0 billion in total liabilities. (Unaudited, interim)

Free cash flow during the nine months ended September 30, 2018, was a negative ($27.8 million).

IPO Details

ARDT intends to raise $100 million in gross proceeds from an IPO of its common stock, not including customary underwriter options. The final figure may be as high as $200 million.

Per the firm’s latest filing, it plans to use the net proceeds from the IPO as follows:

We intend to use the net proceeds from this offering to repay certain outstanding indebtedness and the remainder for general corporate purposes, which may include acquisitions of healthcare facilities or related businesses.

Management’s presentation of the company roadshow is not currently available.

Listed underwriters of the IPO are Barclays, Citigroup, J.P. Morgan, BofA Merrill Lynch, Credit Suisse, Goldman Sachs, RBC Capital Markets, and Loop Capital Markets.

Expected IPO Pricing Date: Not yet on the calendar.

An enhanced version of this article on my Seeking Alpha Marketplace research service IPO Edge includes my initial commentary on the IPO.

Members of IPO Edge get the latest IPO research, news, market trends and industry analysis. Get started with a free trial.

This article was written by

Donovan Jones profile picture
Author of IPO Edge
Get IPO Edge with actionable research on next-generation high growth stocks

I'm the founder of IPO Edge on Seeking Alpha, a research service for investors interested in IPOs on US markets. Subscribers receive access to my proprietary research, valuation, data, commentary, opinions, and chat on U.S. IPOs. Join now to get an insider's 'edge' on new issues coming to market, both before and after the IPO. Start with a 14-day Free Trial.


Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.